EIB supports sustainable growth in Schleswig-Holstein

The European Investment Bank (EIB) has provided the Schleswig-Holstein Investment Bank (IB.SH) with EUR 200 million to finance low-interest loans in support of sustainable growth in Schleswig-Holstein. Projects worth up to EUR 25 million carried out by municipalities and other public sector entities will be eligible for funding. The loan agreement was signed in Kiel today by the Chairman of IB.SH’s Executive Board, Erk Westermann-Lammers, and EIB Director Sandrine Croset.  “This is a substantial sum, which will be available for the next two years. It will enable us to support major projects fostering sustainable growth in the state”, said Mr Westermann-Lammers. The funds are earmarked for projects improving living conditions in both urban and rural areas. Ms Croset stressed that “supporting sustainable growth is one of the EU bank’s priorities. We achieve this by passing on our favourable terms, including longer loan tenors, so that our partner banks and their customers can carry out infrastructure projects directly benefiting the local population.”  In the past 10 years, IB.SH has received EIB funding worth EUR 680 million, which has been used to finance construction in sectors such as broadband, schools, crèches, and water treatment and supply and sanitation. Source: European Investment Bank (EIB) Press Release from March 6th, 2019, https://www.eib.org/en/infocentre/press/releases/all/2019/2019-069-eib-unterstutzt-nachhaltiges-wachstum-in-schleswig-holstein.htm

More News

GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)
GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)

Pacira BioSciences Acquires GQ Bio

HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...

Read more …
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)

CrystalsFirst Scales Operations...

CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...

Read more …
medac has received FDA approval for treosulfan (Copyright Adobe Stock - Nicolas Hermbach)

Strategic cornerstone for medac: FDA approves treosulfan for alloHSCT

medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

Read more …